Dexrazoxane Intravenous and Empagliflozin and linagliptin
Determining the interaction of Dexrazoxane Intravenous and Empagliflozin and linagliptin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Empagliflozin and metformin
- Dexrazoxane Intravenous-Empagliflozin and Metformin Extended-Release Tablets
- Dexrazoxane Intravenous-Empagliflozin and Metformin Tablets
- Dexrazoxane Intravenous-Empliciti
- Dexrazoxane Intravenous-Emsam
- Dexrazoxane Intravenous-Emsam Transdermal
- Empagliflozin and linagliptin-Dextenza Insert
- Empagliflozin and linagliptin-Dextenza intraocular
- Empagliflozin and linagliptin-Dextran 40
- Empagliflozin and linagliptin-Dextran 70 6% in 5% Dextrose high molecular weight
- Empagliflozin and linagliptin-Dextran 75
- Empagliflozin and linagliptin-Dextran high molecular weight